Cargando…
How Do We Start Palliative Care for Patients With End-Stage Liver Disease?
Patients with end-stage liver disease undergo repetitive patterns of recovery and deterioration and are burdened with uncertainty. Although quality of life is low in patients with end-stage liver disease and their family members, few studies have been conducted to identify what palliative care shoul...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963522/ https://www.ncbi.nlm.nih.gov/pubmed/34269708 http://dx.doi.org/10.1097/SGA.0000000000000611 |
_version_ | 1784678006347792384 |
---|---|
author | Kim, Sookyung Lee, Kyunghwa Kim, Changhwan Choi, Jahyun Kim, Sanghee |
author_facet | Kim, Sookyung Lee, Kyunghwa Kim, Changhwan Choi, Jahyun Kim, Sanghee |
author_sort | Kim, Sookyung |
collection | PubMed |
description | Patients with end-stage liver disease undergo repetitive patterns of recovery and deterioration and are burdened with uncertainty. Although quality of life is low in patients with end-stage liver disease and their family members, few studies have been conducted to identify what palliative care should be provided for them. This integrative review aimed to explore palliative care for patients with end-stage liver disease, focusing on the components and outcome measurements for further research. After searching for studies on palliative care for end-stage liver disease published between 1995 and 2017, 12 studies that met the inclusion criteria were analyzed. The common components of palliative care for patients with liver disease were: (a) an interdisciplinary approach, (b) early palliative care, (c) discussion goals of care with patient and family members, (d) symptom management, and (e) psychosocial support. It was reported that patients who were provided palliative care had improved itching, well-being, appetite, anxiety, fatigue, and depression, increased the number of do-not-resuscitate orders, palliative care consultations, and decreased length of stay. These findings could guide the development of palliative care for end-stage liver disease patients. |
format | Online Article Text |
id | pubmed-8963522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89635222022-04-01 How Do We Start Palliative Care for Patients With End-Stage Liver Disease? Kim, Sookyung Lee, Kyunghwa Kim, Changhwan Choi, Jahyun Kim, Sanghee Gastroenterol Nurs Features Patients with end-stage liver disease undergo repetitive patterns of recovery and deterioration and are burdened with uncertainty. Although quality of life is low in patients with end-stage liver disease and their family members, few studies have been conducted to identify what palliative care should be provided for them. This integrative review aimed to explore palliative care for patients with end-stage liver disease, focusing on the components and outcome measurements for further research. After searching for studies on palliative care for end-stage liver disease published between 1995 and 2017, 12 studies that met the inclusion criteria were analyzed. The common components of palliative care for patients with liver disease were: (a) an interdisciplinary approach, (b) early palliative care, (c) discussion goals of care with patient and family members, (d) symptom management, and (e) psychosocial support. It was reported that patients who were provided palliative care had improved itching, well-being, appetite, anxiety, fatigue, and depression, increased the number of do-not-resuscitate orders, palliative care consultations, and decreased length of stay. These findings could guide the development of palliative care for end-stage liver disease patients. Wolters Kluwer Health, Inc. 2022-03 2021-07-13 /pmc/articles/PMC8963522/ /pubmed/34269708 http://dx.doi.org/10.1097/SGA.0000000000000611 Text en © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Gastroenterology Nurses and Associates https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Features Kim, Sookyung Lee, Kyunghwa Kim, Changhwan Choi, Jahyun Kim, Sanghee How Do We Start Palliative Care for Patients With End-Stage Liver Disease? |
title | How Do We Start Palliative Care for Patients With End-Stage Liver Disease? |
title_full | How Do We Start Palliative Care for Patients With End-Stage Liver Disease? |
title_fullStr | How Do We Start Palliative Care for Patients With End-Stage Liver Disease? |
title_full_unstemmed | How Do We Start Palliative Care for Patients With End-Stage Liver Disease? |
title_short | How Do We Start Palliative Care for Patients With End-Stage Liver Disease? |
title_sort | how do we start palliative care for patients with end-stage liver disease? |
topic | Features |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963522/ https://www.ncbi.nlm.nih.gov/pubmed/34269708 http://dx.doi.org/10.1097/SGA.0000000000000611 |
work_keys_str_mv | AT kimsookyung howdowestartpalliativecareforpatientswithendstageliverdisease AT leekyunghwa howdowestartpalliativecareforpatientswithendstageliverdisease AT kimchanghwan howdowestartpalliativecareforpatientswithendstageliverdisease AT choijahyun howdowestartpalliativecareforpatientswithendstageliverdisease AT kimsanghee howdowestartpalliativecareforpatientswithendstageliverdisease |